They demonstrated that the inhibition of the interaction between the BCR-ABL1 CC and HSP90AB1 relocalizes BCR-ABL1 to the nucleus, triggering apoptosis in CML cells. The gene discussed is HSP90AB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.